After four months of using the digital twin platform, patients had an average HbA1c reduction – a measure of blood glucose control – of 3.1 from a baseline average of 8.7.
They have already been proposed to predict cardiovascular disease risk, but collecting measurements of pregnant uteri to inform digital twin models of pregnancy is limited due to safety concerns.